In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Evolent Health Inc (NYSE: EVH) closed at $10.98 in the last session, down -1.35% from day before closing price of $11.13. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 1.26 million shares were traded. EVH stock price reached its highest trading level at $11.09 during the session, while it also had its lowest trading level at $10.79.
Ratios:
We take a closer look at EVH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.79.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 03, 2024, Reiterated its Buy rating but revised its target price to $29 from $36 previously.
On November 08, 2024, Stephens Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $38 to $16.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $35.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when McCarthy Daniel Joseph sold 23,693 shares for $30.89 per share. The transaction valued at 731,790 led to the insider holds 198,809 shares of the business.
McCarthy Daniel Joseph sold 10,469 shares of EVH for $339,008 on Aug 23 ’24. The PRESIDENT now owns 188,340 shares after completing the transaction at $32.38 per share. On Aug 22 ’24, another insider, Weinberg Jonathan, who serves as the General Counsel of the company, sold 42,140 shares for $31.20 each. As a result, the insider received 1,314,706 and left with 167,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1262985472 and an Enterprise Value of 1988778112. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 1.22. Its current Enterprise Value per Revenue stands at 0.807 whereas that against EBITDA is 16.179.
Stock Price History:
Over the past 52 weeks, EVH has reached a high of $35.00, while it has fallen to a 52-week low of $10.53. The 50-Day Moving Average of the stock is -28.77%, while the 200-Day Moving Average is calculated to be -53.25%.
Shares Statistics:
According to the various share statistics, EVH traded on average about 2.55M shares per day over the past 3-months and 2112670 shares per day over the past 10 days. A total of 115.01M shares are outstanding, with a floating share count of 112.73M. Insiders hold about 4.06% of the company’s shares, while institutions hold 110.57% stake in the company. Shares short for EVH as of 1734048000 were 9759756 with a Short Ratio of 3.83, compared to 1731628800 on 10821680. Therefore, it implies a Short% of Shares Outstanding of 9759756 and a Short% of Float of 9.67.
